Back to Search
WILLIAM LIAO, MD
MD
Anesthesiology Physician
NPI: 1023673589IndividualAccepts Medicare
Education
OTHER
Class of 2019
Clinical Trials (3)
3
Linked Trials
1
Recruiting
2
With Results
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
NCT03293030COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Guselkumab Immunogenetics
NCT04645355RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Immunologic Response to Secukinumab in Plaque Psoriasis
NCT02592018COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Generation of a mouse line expressing Sox17-driven Cre recombinase with specific activity in arteries.
PMID 19415628·Genesis·2009
7-preclinical
Crystal structures of extended europium cyanamide-carbodiimide compounds derived from different reaction conditions: temperature-controlled syntheses of In(0.08)Eu4(NCN)3I3, Eu8I9(CN)(NCN)3, and In(0.28)Eu12(NCN)5I(14.91).
PMID 16676933·Inorg Chem·2006
8-other
Eu8(NCN)5-deltaI6+2delta (delta= 0.05): a novel rare-earth carbodiimide iodide containing oligomeric tritetrahedral Eu8 clusters.
PMID 16010341·Chem Commun (Camb)·2005
8-other
Formation of complex three- and one-dimensional interpenetrating networks within carbodiimide chemistry: NCN2(-)-coordinated rare-earth-metal tetrahedra and condensed alkali-metal iodide octahedra in two novel lithium europium carbodiimide iodides, LiEu2(NCN)I3 and LiEu4(NCN)3I3.
PMID 15360237·Inorg Chem·2004
8-other
[Community types, phenology and propagation characteristics of Taxus mairei in north Guangdong].
PMID 12385206·Ying Yong Sheng Tai Xue Bao·2002
8-other
N-p-nitrobenzyloxycarbonyl galactosamine imidate as a glycosyl donor for the efficient synthesis of mucin core-2 analogue.
PMID 10782688·Bioorg Med Chem Lett·2000
8-other
Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study.
PMID 19513578·Osteoporos Int·2010
4-observational
Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin.
PMID 19652968·Cancer Immunol Immunother·2010
2-rct
Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets.
PMID 19450895·Immunobiology·2010
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 240 E 38TH ST
NEW YORK, NY 10016 - Phone
- (310) 561-5418
Quick Facts
- NPI
- 1023673589
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 7
- Clinical Trials
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile